Inhibition of Piezo1 activity can significantly reduce endothelial inflammation induced by shear stress, suggesting that it may become an important therapeutic target for atherosclerosis treatment (Albarrán-Juárez et al., 2018; Shinge et al., 2022; Wang et al., 2022b). This evidence concerns the gene PIEZO1 and atherosclerosis.